This webpage contains promotional information regarding Napp products. The content has been reviewed ny Napp to ensure compliance with the ABPI code of practice for the pharmaseutical industry.
This section provides useful resources to help you provide optimal care.
For your patients who have been prescribed Invokana for the treatment of insufficiently controlled type 2 diabetes.
The Prescribing Tool is a quick reference guide to support clinicians with treatment decisions concerning SGLT2i therapies.